All Stories

  1. Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance

    Article • Current Topics in Medicinal Chemistry, July 2026, Bentham Science Publishers

    Dr. Mohammad Abid

  2. Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae

    Article • Chemistry & Biodiversity, March 2026, Wiley

    Dr. Mohammad Abid

  3. Synthesis, characterization, antifungal, Ct-DNA binding, catalytic activity, DFT and molecular docking studies of transition metal complexes derived from quinoline based ligand ​

    Article • January 2026, Elsevier

    Dr. Mohammad Abid

  4. Design and synthesis of novel 4-hydroxycoumarin-isoxazole adducts for combating bacterial infections

    Article • Journal of Molecular Structure, October 2025, Elsevier

    Dr. Mohammad Abid

  5. Biophysical and Computational Analysis of a Potent Antimalarial Compound Binding to Human Serum Albumin: Insights for Drug–Protein Interaction

    Article • Scientia Pharmaceutica, September 2025, MDPI AG

    Dr. Mohammad Abid

  6. Integrative computational and experimental approaches for identifying potent antimalarials by targeting falcipain-2 of Plasmodium falciparum

    Article • Journal of Biomolecular Structure and Dynamics, June 2025, Taylor & Francis

    Dr. Mohammad Abid

  7. Coumarin 1,4-dihydropyridine hybrids: Synthesis, X-ray structure, cytotoxicity assay, and molecular dynamic simulation studies

    Article • Journal of Molecular Structure, April 2025, Elsevier

    Dr. Mohammad Abid

  8. Biochemistry of Bacterial Biofilm: Insights into Antibiotic Resistance Mechanisms and Therapeutic Intervention

    Article • Life, January 2025, MDPI AG

    Dr. Mohammad Abid

  9. Synthesis and antibacterial evaluation of quinoline–sulfonamide hybrid compounds: a promising strategy against bacterial resistance

    Article • RSC Advances, January 2025, Royal Society of Chemistry

    Dr. Mohammad Abid

  10. Synthesis and Structure–Activity Relationship (SAR) Studies on New 4-Aminoquinoline-Hydrazones and Isatin Hybrids as Promising Antibacterial Agents

    Article • Molecules, December 2024, MDPI AG

    Dr. Mohammad Abid

  11. A Convenient One-Pot Synthesis of Novel Benzimidazole–Thiazinone Derivatives and Their Antimicrobial Activity

    Article • Antibiotics, December 2024, MDPI AG

    Dr. Mohammad Abid

  12. Exploring the Potential of New 7‐Chloroquinoline‐benzylamine Hybrids as Antimicrobials: Synthesis, Biological Activity and MD Simulation Studies

    Article • ChemistrySelect, September 2024, Wiley

    Dr. Mohammad Abid

  13. Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma

    Article • ACS Omega, June 2024, American Chemical Society (ACS)

    Dr. Mohammad Abid

  14. Evaluating Terrestrol A as an Inhibitor Against SARS‐CoV‐2and Invasive Fungal Pathogens: A Comprehensive Computational Analysis

    Article • ChemistrySelect, April 2024, Wiley

    Dr. Mohammad Abid

  15. Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders

    Article • European Journal of Medicinal Chemistry, February 2024, Elsevier

    Dr. Mohammad Abid

  16. A Comprehensive Multispectroscopic and Computational Analysis of the Interaction between Plant-Based Antiplasmodial Compounds and Bovine Serum Albumin

    Article • ACS Omega, January 2024, American Chemical Society (ACS)

    Dr. Mohammad Abid

  17. Synthesis of 1,2,4‐Oxadiazole‐sulfonamide Conjugates and Their Synergistic Effect with Ampicillin as Antimicrobial Agents

    Article • ChemistrySelect, December 2023, Wiley

    Dr. Mohammad Abid

  18. Comparative investigation on interaction between potent antimalarials and human serum albumin using multispectroscopic and computational approaches

    Article • Luminescence, September 2023, Wiley

    Dr. Mohammad Abid

  19. Microbial Biofilms: Applications, Clinical Consequences, and Alternative Therapies

    Article • Microorganisms, July 2023, MDPI AG

    Dr. Mohammad Abid

  20. Synergistic antimicrobial activity, MD simulation studies and crystal structure of natural alcohol motif containing novel substituted cinnamates

    Article • Journal of Biomolecular Structure and Dynamics, March 2023, Taylor & Francis

    Dr. Mohammad Abid

  21. Synthesis, spectral characterization of pyrazole derived Schiff base analogs: molecular dynamic simulation, antibacterial and DNA binding studies

    Article • Journal of Biomolecular Structure and Dynamics, February 2023, Taylor & Francis

    Dr. Mohammad Abid

  22. Design, Synthesis and Mechanistic Studies of Novel Isatin-Pyrazole Hydrazone Conjugates as Selective and Potent Bacterial MetAP Inhibitors

    Article • Antibiotics, August 2022, MDPI AG

    Dr. Mohammad Abid

  23. A multi-spectroscopic and computational simulations study to delineate the interaction between antimalarial drug hydroxychloroquine and human serum albumin

    Article • Journal of Biomolecular Structure and Dynamics, August 2022, Taylor & Francis

    Dr. Mohammad Abid, Dr. Taj Mohammad

  24. Prefoldin subunit 6 of Plasmodium falciparum binds merozoite surface protein‐1

    Article • FEBS Open Bio, March 2022, Wiley

    Dr. Mohammad Abid

  25. Mannose 2, 3, 4, 5, 6-O-pentasulfate (MPS): a partial activator of human heparin cofactor II with anticoagulation potential

    Article • Journal of Biomolecular Structure and Dynamics, March 2022, Taylor & Francis

    Dr. Mohammad Abid

  26. Structural-activity Relationship of Metallo-aminoquines as Next Generation Antimalarials

    Article • Current Topics in Medicinal Chemistry, March 2022, Bentham Science Publishers

    Dr. Mohammad Abid

  27. Medicinal chemistry updates on quinoline- and endoperoxide-based hybrids with potent antimalarial activity

    Article • RSC Medicinal Chemistry, January 2021, Royal Society of Chemistry

    Dr. Mohammad Abid

  28. Metacaspase-3 of Plasmodium falciparum: An atypical trypsin-like serine protease

    Article • International Journal of Biological Macromolecules, October 2019, Elsevier

    Dr. Mohammad Abid

  29. Design, Synthesis, and Biological Evaluation of Novel Fused Spiro-4H-Pyran Derivatives as Bacterial Biofilm Disruptor

    Article • ACS Omega, September 2019, American Chemical Society (ACS)

    Dr. Mohammad Abid

  30. Synthesis of Novel Benzimidazolium Gemini Surfactants and Evaluation of Their Anti-Candida Activity

    Article • ACS Omega, July 2019, American Chemical Society (ACS)

    Dr. Mohammad Abid

  31. Synthesis, Antimicrobial Evaluation and In silico Studies of Novel 2,4- disubstituted-1,3-thiazole Derivatives

    Article • Letters in Drug Design & Discovery, November 2018, Bentham Science Publishers

    Mr Mohammad Irfan, Professor amir azam, Dr. Mohammad Abid, Dr Mir Mohammad Masood, Muhammad zahid

  32. Antithrombotic potential of esculin 7, 3′, 4′, 5′, 6′-O-pentasulfate (EPS) for its role in thrombus reduction using rat thrombosis model

    Article • International Journal of Biological Macromolecules, November 2018, Elsevier

    Dr. Mohammad Abid

  33. The Upshot of PI3K Inhibitors as Anticancer Arsenal: A Short Review

    Article • Current Bioactive Compounds, October 2018, Bentham Science Publishers

    Dr. Mohammad Abid

  34. Effect of triazole-tryptophan hybrid on the conformation stability of bovine serum albumin

    Article • Luminescence, January 2018, Wiley

    Dr Rajan Patel, Dr. Mohammad Abid

  35. Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein

    Article • Current Medicinal Chemistry, January 2018, Bentham Science Publishers

    Dr. Mohammad Abid, Yogesh Sonawane

  36. 1,2,3-Triazole–quinazolin-4(3H)-one conjugates: evolution of ergosterol inhibitor as anticandidal agent

    Article • RSC Advances, January 2018, Royal Society of Chemistry

    Dr Mir Mohammad Masood, Dr. Mohammad Abid

  37. Anti-leishmanial and cytotoxic activities of amino acid-triazole hybrids: Synthesis, biological evaluation, molecular docking and in silico physico-chemical properties

    Article • Bioorganic & Medicinal Chemistry Letters, May 2017, Elsevier

    Dr Mir Mohammad Masood, Dr. Mohammad Abid

  38. Effect of quinoline based 1,2,3-triazole and its structural analogues on growth and virulence attributes of Candida albicans

    Article • PLOS One, April 2017, PLOS

    Dr. Mohammad Abid

  39. Synthesis, Antimicrobial Studies, and Docking Simulations of New Bis(4,5‐dihydropyrazole) Derivatives

    Article • Journal of Heterocyclic Chemistry, March 2017, Wiley

    Dr. Mohammad Abid

  40. Efficient synthesis of novel N-substituted 2-carboxy-4-quinolones via lithium bis(trimethylsilyl)amide (LiHMDS)-induced in situ cyclocondensation reaction

    Article • RSC Advances, January 2017, Royal Society of Chemistry

    Dr Mir Mohammad Masood, Dr. Mohammad Abid

  41. Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)

    Article • Chemical Communications, January 2017, Royal Society of Chemistry

    Dr. Mohammad Abid

  42. Biological Activities and In Silico Physico-Chemical Properties of 1,2,3- Triazoles Derived from Natural Bioactive Alcohols

    Article • Anti-Infective Agents, September 2016, Bentham Science Publishers

    Dr. Mohammad Abid

  43. Experimental and molecular docking investigation on DNA interaction ofN-substituted phthalimides: antibacterial, antioxidant and hemolytic activities

    Article • Luminescence, July 2016, Wiley

    Dr. Mohammad Abid, Dr RAHIS UDDIN

  44. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy

    Article • Mini-Reviews in Medicinal Chemistry, May 2016, Bentham Science Publishers

    Dr. Mohammad Abid

  45. ChemInform Abstract: A Structure Guided Drug-Discovery Approach Towards Identification of Plasmodium Inhibitors

    Article • ChemInform, March 2016, Wiley

    Dr. Mohammad Abid

  46. A structure guided drug-discovery approach towards identification of Plasmodium inhibitors

    Article • RSC Advances, January 2016, Royal Society of Chemistry

    Dr. Mohammad Abid

  47. Effect of novel triazole–amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies

    Article • Organic & Biomolecular Chemistry, January 2016, Royal Society of Chemistry

    Dr. Mohammad Abid

  48. Evaluation of DNA Binding, Radicals Scavenging and Antimicrobial Studies of Newly Synthesized N-Substituted Naphthalimides: Spectroscopic and Molecular Docking Investigations

    Article • Journal of Fluorescence, October 2015, Springer Science + Business Media

    Dr. Mohammad Abid

  49. Monocyclic β -lactam and unexpected oxazinone formation: synthesis, crystal structure, docking studies and antibacterial evaluation

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, July 2015, Informa Healthcare

    Dr. Mohammad Abid

  50. Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds

    Article • European Journal of Medicinal Chemistry, March 2015, Elsevier

    Dr. Mohammad Abid

  51. Diketo acids and their amino acid/dipeptidic analogues as promising scaffolds for the development of bacterial methionine aminopeptidase inhibitors

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Dr. Mohammad Abid, Dr Mir Mohammad Masood

  52. Polysulfated Trehalose as a Novel Anticoagulant Agent with Dual Mode of Action

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr. Mohammad Abid

  53. Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition

    Article • Journal of Natural Science Biology and Medicine, January 2014, Medknow

    Dr. Mohammad Abid

  54. Synthesis of N-2-aryl-substituted-1,2,3-triazole Derivatives as Novel Inhibitors of Entamoeba histolytica

    Article • January 2014, Sciknow Publications

    Dr. Mohammad Abid

  55. Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin

    Article • Journal of Thrombosis and Thrombolysis, March 2012, Springer Science + Business Media

    Dr. Mohammad Abid

  56. ChemInform Abstract: Synthesis, Spectral Studies and Antiamoebic Activity of New 1-N-Substituted Thiocarbamoyl-3-phenyl-2-pyrazolines.

    Article • ChemInform, May 2009, Wiley

    Dr. Mohammad Abid

  57. Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines

    Article • European Journal of Medicinal Chemistry, January 2009, Elsevier

    Dr. Mohammad Abid

  58. Synthesis and antiamoebic activity of metronidazole thiosemicarbazone analogues

    Article • European Journal of Medicinal Chemistry, September 2008, Elsevier

    Dr. Mohammad Abid, Dr Subhash Mohan Agarwal

  59. Novel Pd(II) complexes of 1-N-substituted 3-phenyl-2-pyrazoline derivatives and evaluation of antiamoebic activity

    Article • European Journal of Medicinal Chemistry, February 2008, Elsevier

    Dr. Mohammad Abid

  60. Synthesis, characterization and antiamoebic activity of new indole-3-carboxaldehyde thiosemicarbazones and their Pd(II) complexes

    Article • European Journal of Medicinal Chemistry, October 2007, Elsevier

    Dr. Mohammad Abid

  61. Syntheses, characterization and in vitro antiamoebic activity of new Pd(II) complexes with 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives

    Article • European Journal of Medicinal Chemistry, April 2007, Elsevier

    Dr. Mohammad Abid

  62. Synthesis, Characterization and Antiamoebic Activity of 1-(Thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline Derivatives.

    Article • ChemInform, August 2006, Wiley

    Dr. Mohammad Abid

  63. Synthesis, characterization and antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives

    Article • Bioorganic & Medicinal Chemistry Letters, May 2006, Elsevier

    Dr. Mohammad Abid

  64. Dioxovanadium(V) and μ-oxo bis[oxovanadium(V)] complexes containing thiosemicarbazone based ONS donor set and their antiamoebic activity

    Article • Inorganica Chimica Acta, May 2006, Elsevier

    Dr. Mohammad Abid

  65. 1-N-Substituted Thiocarbamoyl-3-phenyl-2-pyrazolines: Synthesis and in vitro Antiamoebic Activities.

    Article • ChemInform, February 2006, Wiley

    Dr. Mohammad Abid

  66. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(iv), oxovanadium(v) and µ-bis(oxo)bis{oxovanadium(v)} complexes

    Article • Dalton Transactions, January 2006, Royal Society of Chemistry

    Dr. Mohammad Abid

  67. Synthesis and Anti-Amoebic Activity of Gold(I), Ruthenium(II), and Copper(II) Complexes of Metronidazole

    Article • Chemistry & Biodiversity, October 2005, Wiley

    Dr Simon J Coles, Dr. Mohammad Abid, Dr Subhash Mohan Agarwal

  68. Synthesis and antiamoebic activity of new oxime ether derivatives containing 2-acetylpyridine/2-acetylfuran

    Article • Bioorganic & Medicinal Chemistry Letters, October 2005, Elsevier

    Dr. Mohammad Abid

  69. Synthesis and antiamoebic activities of 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones

    Article • Bioorganic & Medicinal Chemistry, March 2005, Elsevier

    Dr. Mohammad Abid